CTLA4 and neoplasm: We hypothesized that ALPN-202 was unable to induce CD28 costimulation in this model because of its inability to bind mouse PD-L1 and thus the anti-tumor activity was only due to ALPN-202’s ability to bind and block CTLA-4.